<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587753</url>
  </required_header>
  <id_info>
    <org_study_id>Oxlip-2013 sub amend</org_study_id>
    <nct_id>NCT03587753</nct_id>
  </id_info>
  <brief_title>Experiment 2: Understanding Liver Fat Metabolism</brief_title>
  <acronym>FATOX</acronym>
  <official_title>Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Nutrients on Liver Fat Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a largely unsubstantiated thought in the literature that dietary unsaturated enter&#xD;
      oxidation pathways preferentially compared to saturated fatty acids. This study is&#xD;
      undertaking a direct comparison of the oxidation of dietary saturated and unsaturated fatty&#xD;
      acids.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Provided subjects meet the inclusion criteria, then at least one week after the screening&#xD;
      visit volunteers will then undertake the first two 'study days'. There will be two study days&#xD;
      on separate occasions that will be up to 3 weeks apart. Each study day will be approximately&#xD;
      7 hours in duration. On each study day participants will be given a standardised 'test' meal&#xD;
      that contains specially labelled fat molecules (stable-isotope tracer) and then repeated&#xD;
      breath and blood samples will be taken over the course of the next 6 hours. The test meal&#xD;
      consumed on each 'study day' will be identical in composition with only the specially&#xD;
      labelled fat molecules being different (either unsaturated or saturated fat) and these will&#xD;
      be given in a random order.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomised cross-over</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dietary fatty acid partitioning</measure>
    <time_frame>6 hours</time_frame>
    <description>The appearance of the 13Clabelled fatty acid in plasma triglycerides</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Fatty Acid Oxidation</condition>
  <arm_group>
    <arm_group_label>Unsaturated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A test meal containing a unsaturated fatty acid labelled with 13C to measure hepatic fatty acid partitioning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saturated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A test meal containing a saturated fatty acid labelled with 13C to measure hepatic fatty acid partitioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary fatty acid partitioning</intervention_name>
    <description>There is no intervention as such, just a physiological assessment of the partitioning and oxidation of two different types of dietary fatty acids</description>
    <arm_group_label>Saturated</arm_group_label>
    <arm_group_label>Unsaturated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participant is willing and able to give informed consent for participation in the study.&#xD;
&#xD;
        Male or Female, aged &gt;18 and &lt;65 years BMI &gt;19 &lt;35kg/m2 No medical condition or relevant&#xD;
        drug therapy known to affect liver metabolism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Age &lt;18 or &gt;65 years&#xD;
&#xD;
               -  Body mass index &lt;19 or &gt;35kg/m2&#xD;
&#xD;
               -  A blood haemoglobin &lt;120mg/dL&#xD;
&#xD;
               -  Any metabolic condition or relevant drug therapy&#xD;
&#xD;
               -  Smoking&#xD;
&#xD;
               -  History of alcoholism or a greater than recommended alcohol intake&#xD;
&#xD;
               -  Pregnant or nursing mothers&#xD;
&#xD;
               -  Women prescribed hormone replacement therapy (HRT) or who have used this within&#xD;
                  the last 12 months&#xD;
&#xD;
               -  History of severe claustrophobia&#xD;
&#xD;
               -  Presence of metallic implants, pacemaker&#xD;
&#xD;
               -  Haemorrhagic disorders&#xD;
&#xD;
               -  Anticoagulant treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oxford Centre for Diabetes, Endocrinology and Metabolism</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

